Clal Biotechnology Industries Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 2

Professionals

  • Investments
  • 65

  • Portfolio
  • 3

  • Exits
  • 29

Exits

Clal Biotechnology Industries General Information

Company Description

Founded in 1993, Clal Biotechnology Industries is a venture capital investment firm based in Tel Aviv, Israel. The firm prefers to invest in companies operating in the biotech, pharma, diagnostics, and medical devices sectors. The firm prefers to invest in companies based in Israel and the United States.

Business Details

Website
www.cbi.co.il
Formerly Known As
Access BridgeGap Ventures
Year Founded
1993
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
PE/Buyout
Corporate Office
  • Triangle Building 45th floor
  • Azrieli Center
  • Tel Aviv 67023
  • Israel
+972

Clal Biotechnology Industries Investments (65)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
eXIthera Pharmaceuticals 01-Jul-2022 Later Stage VC Drug Discovery Clinical Trials - Phase 1
Elicio Therapeutics 17-Feb-2021 Drug Discovery Generating Revenue
Sight Diagnostics 01-Jul-2020 Diagnostic Equipment Generating Revenue
Cadent Therapeutics 29-Apr-2020 Drug Discovery Clinical Trials - Phase 2
Pi-Cardia 20-Apr-2020 Surgical Devices Generating Revenue
MinInvasive 22-Oct-2019 Other Devices and Supplies Out of Business
Elicio Therapeutics 01-Apr-2019 Drug Discovery Generating Revenue
Sight Diagnostics 14-Feb-2019 Diagnostic Equipment Generating Revenue
MinInvasive 02-Oct-2018 Later Stage VC Other Devices and Supplies Out of Business
Colospan 24-Sep-2017 Later Stage VC Surgical Devices Clinical Trials - General
You’re viewing 10 of 65 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clal Biotechnology Industries Exits (29)

Company Name Exit Date Exit Type Exit Size
Colospan 22-Jun-2026 Merger/Acquisition
eXIthera Pharmaceuticals 15-Sep-2025
VacciGuard 19-Nov-2024
Gamida Cell 13-May-2024
Elicio Therapeutics 01-Jun-2023
MinInvasive 01-Mar-2023
Cadent Therapeutics 31-Mar-2021
Anchiano Therapeutics 16-Mar-2021
Gamida Cell 28-Jun-2019 Public Investment 2nd Offering
Gamida Cell 26-Oct-2018 IPO
You’re viewing 10 of 29 exits. Get the full list »

Clal Biotechnology Industries Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Clal Biotechnology Industries Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Biomedical Investments Tel Aviv, Israel 1997

Clal Biotechnology Industries FAQs

  • What is Clal Biotechnology Industries?

    Founded in 1993, Clal Biotechnology Industries is a venture capital investment firm based in Tel Aviv, Israel.

  • When was Clal Biotechnology Industries founded?

    Clal Biotechnology Industries was founded in 1993.

  • Where is Clal Biotechnology Industries headquartered?

    Clal Biotechnology Industries is headquartered in Tel Aviv, Israel.

  • How many investments has Clal Biotechnology Industries made?

    Clal Biotechnology Industries has made 65 investments.

  • What has Clal Biotechnology Industries invested in?

    Clal Biotechnology Industries has made numerous investments in companies like eXIthera Pharmaceuticals, Elicio Therapeutics, and Sight Diagnostics within the Drug Discovery and Diagnostic Equipment industries.

  • What has Clal Biotechnology Industries invested in recently?

    Clal Biotechnology Industries's latest investment was on 01-Jul-2022 in eXIthera Pharmaceuticals, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process